Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oramed Pharmaceuticals (ORMP) Times Interest Earned (2023 - 2024)

Oramed Pharmaceuticals' Times Interest Earned history spans 2 years, with the latest figure at -$12.01 for Q2 2024.

  • For Q2 2024, Times Interest Earned changed N/A year-over-year to -$12.01; the TTM value through Jun 2025 reached -$50.62, down 3785.26%, while the annual FY2024 figure was -$3.92, 847.49% down from the prior year.
  • Times Interest Earned reached -$12.01 in Q2 2024 per ORMP's latest filing, down from -$5.0 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $10.7 in Q4 2023 to a low of -$12.01 in Q2 2024.